Login to Your Account



U.S. Patent Disclosures


Monday, July 1, 2013
• Amarin Corp. plc, of Dublin, was issued U.S. Patent notice of allowance No. 13/417,899, "Pharmaceutical Compositions Comprising EPA and a Cardiovascular Agent and Methods of Using the Same." The application covers the use of Vascepa (icosapent ethyl) and statin therapy to reduce triglycerides.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription